Ann: Partnership with Canadian-based Radient Technologies Inc., page-2

Good partnership. Can you see where it's going?

AEB is setting the stage to really kick things off quickly when they have medicinal cannabis.

They're developing the approach with Radient's technology for a better extraction, and then, guess what, that's one the synergies we want to see, when MC is ready, it goes straight into the same process and gets a quality extraction.

This is good because: it's helping the nutraceutical algae division to make higher quality (higher margin) products and it's good because it'll be used later for medicinal cannabis (potentially CBD extracts and just nutraceutical).

Would you buy a top spirulina + CBD supplement?

The announcements make sense, and what they're cooking smells good. The only dark spot is the finances. If we get clarity on that or revenue dropping in Q4, then the SP will start recapturing the highs as I believe this is the main risk the market is factoring in.

Does that mean we can finally use our stock and produce high margin revenue from it? Would it drop in Q4 as revenue?

Some pieces of the puzzle in the ann. Good.